CYC vs RAD

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

39LOW

RAD

RADIOPHARM FPO [RAD]

39LOW

Score Breakdown

CYC RAD
Technical
33
48
Catalyst
50
42
Sentiment
50
50
Fundamental
69
76
Momentum
39
45
Risk Gate
50
27

Key Metrics

CYC Metric RAD
$70.4MMarket Cap$44.9M
139KAvg Volume (20d)4.3M
N/AShort Interest+0.0%
$1.29052-Week High$0.040
$0.45052-Week Low$0.017
-1.8%Daily Change+0.0%
$0.550Reference Price$0.019
-49.3%ROE-92.1%
-53.3%Profit Margin-286.2%

Active Signals

CYC Signals

Watch out — volume is flowing out even as price holds up. Distribution pattern
Drifting lower — down 4.3% over the last 5 days
Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.5 quarters)
Low P/S ratio (2.2x)
Moderate revenue growth (+10%)

RAD Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Trading below both moving averages — the trend is working against this one
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Low cash runway (4 quarters) - dilution risk
Low P/S ratio (2.8x)

Ask Scout AI to compare CYC and RAD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs IMR →CYC vs SHG →RCE vs TRU →RNV vs TRU →RAD vs TRU →
CYC Full Analysis → RAD Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).